Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Kiek, Verrijp"'
Autor:
Lotte Bakkerus, Beatriz Subtil, Hetty J. Bontkes, Elske C. Gootjes, Martine Reijm, Manon Vullings, Kiek Verrijp, John-Melle Bokhorst, Carmen Woortman, Iris D. Nagtegaal, Marianne A. Jonker, Hans J. van der Vliet, Cornelis Verhoef, Mark A.J. Gorris, I. Jolanda M. de Vries, Tanja D. de Gruijl, Henk M.W. Verheul, Tineke E. Buffart, Daniele V. F. Tauriello
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
Colorectal cancer (CRC) raises considerable clinical challenges, including a high mortality rate once the tumor spreads to distant sites. At this advanced stage, more accurate prediction of prognosis and treatment outcome is urgently needed. The role
Externí odkaz:
https://doaj.org/article/d840e76947914521ba035fcfccc6eb05
Autor:
Kim Monkhorst, Johannes Textor, Michel M van den Heuvel, Katrien Grünberg, Jeroen H A Creemers, Carl G Figdor, I Jolanda M de Vries, Lieke L van der Woude, Mark A J Gorris, Inge M N Wortel, Kiek Verrijp, Berber Piet, Willemijn S M E Theelen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 10 (2022)
Background Immunotherapy is currently part of the standard of care for patients with advanced-stage non-small cell lung cancer (NSCLC). However, many patients do not respond to this treatment, therefore combination strategies are being explored to in
Externí odkaz:
https://doaj.org/article/663cd6a76af94357ad61372c788c6ddb
Autor:
Kalijn Bol, Johannes Textor, Carl G Figdor, I Jolanda M de Vries, Lieke L van der Woude, Mark A J Gorris, Kiek Verrijp, Leonie I Kroeze, Avital L Amir, Jelena Meek
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 5 (2022)
Background Immune checkpoint inhibitors (ICI) can lead to long-term responses in patients with metastatic melanoma. Still many patients with melanoma are intrinsically resistant or acquire secondary resistance. Previous studies have used primary or m
Externí odkaz:
https://doaj.org/article/97f866204a9743d2b373139e6fe20a1d
Autor:
Stefan G. van Ravensteijn, Yvonne M. H. Versleijen-Jonkers, Melissa H. S. Hillebrandt-Roeffen, Marije E. Weidema, Maikel J. L. Nederkoorn, Kalijn F. Bol, Mark A. J. Gorris, Kiek Verrijp, Leonie I. Kroeze, Tessa J. J. de Bitter, Richarda M. de Voer, Uta E. Flucke, Ingrid M. E. Desar
Publikováno v:
Cancers, Vol 14, Iss 23, p 5938 (2022)
Angiosarcomas (AS) are extremely rare and aggressive vascular malignancies subdivided in de novo primary AS (pAS) and secondary AS (sAS). We hypothesize that the combination of immunological and genomic profiles significantly differs between primary
Externí odkaz:
https://doaj.org/article/5be8092c919940ac829d3543a62c1238
Autor:
Lieke L van der Woude, Mark A J Gorris, Inge M N Wortel, Jeroen H A Creemers, Kiek Verrijp, Kim Monkhorst, Katrien Grünberg, Michel M van den Heuvel, Johannes Textor, Carl G Figdor, Berber Piet, Willemijn S M E Theelen, I Jolanda M de Vries
Publikováno v:
Journal for Immunotherapy of Cancer, 10
Journal for Immunotherapy of Cancer, 10, 10
Journal for Immunotherapy of Cancer, 10, 10
BackgroundImmunotherapy is currently part of the standard of care for patients with advanced-stage non-small cell lung cancer (NSCLC). However, many patients do not respond to this treatment, therefore combination strategies are being explored to inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f72befe4acddd9e0159627d71ac430c
http://hdl.handle.net/2066/283861
http://hdl.handle.net/2066/283861
Autor:
Mark A J Gorris, Lieke L van der Woude, Leonie I Kroeze, Kalijn Bol, Kiek Verrijp, Avital L Amir, Jelena Meek, Johannes Textor, Carl G Figdor, I Jolanda M de Vries
Publikováno v:
Journal for Immunotherapy of Cancer, 10, 1-12
Journal for Immunotherapy of Cancer, 10, 5, pp. 1-12
Journal for Immunotherapy of Cancer, 10, 5, pp. 1-12
BackgroundImmune checkpoint inhibitors (ICI) can lead to long-term responses in patients with metastatic melanoma. Still many patients with melanoma are intrinsically resistant or acquire secondary resistance. Previous studies have used primary or me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::586e4a82bca71d3925c32ffcd0ffafb3
https://doi.org/10.1136/jitc-2021-004329
https://doi.org/10.1136/jitc-2021-004329
Autor:
Carl G. Figdor, Sandra van Wilpe, I. Jolanda M. de Vries, Kiek Verrijp, Shabaz Sultan, Evgenia Martynova, Johannes Textor, Lieke L. van der Woude, Mark A.J. Gorris, Franka Buytenhuijs
Tissue specimens taken from primary tumors or metastases contain important information for diagnosis and treatment of cancer patients. Multispectral imaging allows in situ visualization of heterogeneous cell subsets, such as lymphocytes, in tissue sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10aa52625edd870a90d2520f92ae45a5
https://doi.org/10.1101/2021.10.22.464548
https://doi.org/10.1101/2021.10.22.464548
Autor:
Stefan G. van Ravensteijn, Yvonne M. Versleijen-Jonkers, Melissa H. Hillebrandt-Roeffen, Maikel Nederkoorn, Mark A. Gorris, Kiek Verrijp, Leonie I. Kroeze, Tessa J. de Bitter, Richarda M. de Voer, Uta E. Flucke, Ingrid M. Desar
Publikováno v:
Cancer Research. 82:LB140-LB140
Background: Angiosarcomas (AS) are a rare heterogenous group of soft tissue sarcomas (STS) that form in the lining of blood vessels or lymphatic vessels. They comprise of primary (de novo) AS and secondary AS. The etiology of primary AS is unknown. S
Autor:
Anna C Navis, Annika Bourgonje, Pieter Wesseling, Alan Wright, Wiljan Hendriks, Kiek Verrijp, Jeroen A W M van der Laak, Arend Heerschap, William P J Leenders
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e58262 (2013)
Anti-angiogenic treatment of glioblastoma with Vascular Endothelial Growth Factor (VEGF)- or VEGF Receptor 2 (VEGFR2) inhibitors normalizes tumor vessels, resulting in a profound radiologic response and improved quality of life. This approach however
Externí odkaz:
https://doaj.org/article/832765bc2d2a4943b0c5216a995a7a68
The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture
Autor:
Marcella Tazzari, G. F. van Wigcheren, Kiek Verrijp, Stanleyson V. Hato, S. Di Blasio, E. van den Bogaard, J.H.W. de Wilt, Ghaith Bakdash, A. van Duffelen, Gert Jan Bakker, Angela Vasaturo, Altuna Halilovic, Joost Schalkwijk, Johannes Textor, Anouk M. D. Becker, Irene Stefanini, Carl G. Figdor, Mark A.J. Gorris, I.J.M. de Vries, Martine Bloemendal
Publikováno v:
Nature Communications
Nature Communications, Vol 11, Iss 1, Pp 1-17 (2020)
Nature Communications, 11
Nature Communications, 11, 1
Nature Communications, Vol 11, Iss 1, Pp 1-17 (2020)
Nature Communications, 11
Nature Communications, 11, 1
The tumour microenvironment (TME) forms a major obstacle in effective cancer treatment and for clinical success of immunotherapy. Conventional co-cultures have shed light onto multiple aspects of cancer immunobiology, but they are limited by the lack